Integrative analysis of clinical and epigenetic biomarkers of mortality is a research paper published in Aging Cell (2022). On theSindex it has a DataRank of 0.561. It has been cited 41 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.561
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK063491
National Institutes of Health
Grant: HHSN268201500001I
National Institutes of Health
Grant: N01‐HC‐25195
National Institute on Aging
Grant: R01AG023629
National Center for Advancing Translational Sciences
Grant: UL1TR000124
National Heart, Lung, and Blood Institute
Grant: HHSN268200800007C
National Heart, Lung, and Blood Institute
Grant: HHSN268201200036C
National Heart, Lung, and Blood Institute
Grant: HHSN268201800001C
National Heart, Lung, and Blood Institute
Grant: K08HL116640
National Heart, Lung, and Blood Institute
Grant: N01HC55222
National Heart, Lung, and Blood Institute
Grant: N01HC85079
National Heart, Lung, and Blood Institute
Grant: N01HC85080
National Heart, Lung, and Blood Institute
Grant: N01HC85081
National Heart, Lung, and Blood Institute
Grant: N01HC85082
National Heart, Lung, and Blood Institute
Grant: N01HC85083
National Heart, Lung, and Blood Institute
Grant: N01HC85086
National Heart, Lung, and Blood Institute
Grant: R01HL087652
National Heart, Lung, and Blood Institute
Grant: R01HL092111
National Heart, Lung, and Blood Institute
Grant: R01HL103612
National Heart, Lung, and Blood Institute
Grant: R01HL105756
National Heart, Lung, and Blood Institute
Grant: R01HL111089
National Heart, Lung, and Blood Institute
Grant: R01HL116747
National Heart, Lung, and Blood Institute
Grant: R01HL120393
National Heart, Lung, and Blood Institute
Grant: U01HL080295
National Heart, Lung, and Blood Institute
Grant: U01HL130114
NIA NIH HHS
Grant: T32 AG058529
Medical Research Council
Grant: MR/K026992/1
NHLBI NIH HHS
Grant: N01 HC055222
NHLBI NIH HHS
Grant: N01 HC085080
NHLBI NIH HHS
Grant: N01 HC085083
NHLBI NIH HHS
Grant: N01 HC085079
NHLBI NIH HHS
Grant: N01 HC085081
NIDDK NIH HHS
Grant: P30 DK063491
Medical Research Council
Grant: G0700704
NHLBI NIH HHS
Grant: N01 HC085086
NHLBI NIH HHS
Grant: HHSN268201500001C
Medical Research Council
Grant: MR/T030852/1
NIH HHS
Grant: N01-HC-25195
NHLBI NIH HHS
Grant: N01 HC085082
NCATS NIH HHS
Grant: UL1 TR001881
MeSH Terms
Keywords
Additional file 1 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 1 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 2 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 2 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 4 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 4 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 5 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 5 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 6 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 6 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 7 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 7 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 8 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 8 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 9 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 9 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 10 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 10 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 3 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Additional file 3 of DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes